Location History:
- Gedero, IL (2009)
- Gedera, IL (2010 - 2011)
Company Filing History:
2 out of 119 
2 out of 102 
1 out of 155 
Years Active: 2009-2011
Title: Mina Fogel: Innovator in Cancer Treatment
Introduction
Mina Fogel is a notable inventor based in Gedera, Israel, recognized for his contributions to the field of cancer treatment. With a total of 3 patents, Fogel has made significant strides in developing pharmaceutical compositions aimed at combating carcinomas.
Latest Patents
Fogel's latest patents include innovative approaches to treating carcinomas. One of his key inventions is a pharmaceutical composition that comprises compounds interfering with the biological activity of L1 and/or ADAM10. This composition is designed for the prevention and treatment of carcinomas, including ovarian and endometrial carcinoma. Additionally, he has developed diagnostic methods based on the determination of L1 and/or ADAM10 activity, which can help identify highly malignant forms of carcinomas. Another significant patent involves diagnostic and therapeutic methods based on the L1 adhesion molecule, which aids in diagnosing ovarian or endometrial tumors by determining L1 levels in patient samples.
Career Highlights
Throughout his career, Mina Fogel has worked with esteemed organizations such as the Deutsches Krebsforschungszentrum and Mor Research Applications Ltd. His work has focused on advancing cancer research and developing effective treatment methodologies.
Collaborations
Fogel has collaborated with notable professionals in the field, including Peter Altevogt and Daniela Kelm, who have contributed to his research endeavors.
Conclusion
Mina Fogel's innovative work in cancer treatment showcases his dedication to improving patient outcomes through scientific research and development. His patents reflect a commitment to addressing critical health challenges in oncology.